Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis

Nephron - Clinical Practice

Volumn 110, Issue 2, 2008, Pages

  Takeda, Atsushi ^a,d   Toda, Takayuki ^a   Iwamoto, Hitoshi ^b   Watanabe, Kotaro ^c   Matsui, Noriaki ^a  

^a TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^b Iwamoto Clinic   (Japan)

^c Watanabe Naika Clinic   (Japan)

^d Midorino Clinic   (Japan)

Author keywords

Blood pressure; Hemodialysis; Left ventricular hypertrophy

Indexed keywords

SERUM ALBUMIN;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART SIZE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 53849103984     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163845     Document Type: Article

References (31)

1. Akiba T, Nakai S, Shinzato T, Kitaoka T, Kubo K, Maeda K: Why has the gross mortality of dialysis patients increased in Japan? Kidney Int 2000;57(suppl 74):S60-S65.
2. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 2003;64(suppl 87):S24-S31.
3. Zoccali C, Benedetto FA, Mallamaci F, et al: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001;12:2768-2774.
4. Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
5. Zoccali C, Benedetto FA, Mallamaci F, et al: Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2004;15:1029-1037.
6. London GM, Marchais SJ, Guérin AP, Fabiani F, Métivier F: Cardiovascular function in hemodialysis patients; in Grünfeld JP, Bach JF, Funck-Brentano JL, Maxwell MH (eds): Advances in Nephrology. St. Louis, Mosby-Year Book, vol 20, 1991, pp 249-273.
7. London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B: Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. Kidney Int 1993;41(suppl 41):S42-S49.
8. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994;4:1486-1490.
9. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end stage renal disease. J Am Soc Nephrol 2000;11:912-916.
10. London GM, Pannier B, Guerin AP, et al: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12:2759-2767.
11. Zoccali C, Benedetto FA, Mallamaci F, et al: Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004;65:1492-1498.
12. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-618.
13. Pombo JF, Troy BL, Russell RO Jr: Left ventricular volumes and ejection fraction by echocardiography. Circulation 1971;43:480-490.
14. Levy D, Savage DD, Garrison RJ, et al: Echocardiographic criteria for left ventricular hypertrophy. The Framingham Study. Am J Cardiol 1987;59:956-960.
15. Cannella G, Paoletti E, Barocci S, et al: Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int 1998;54:618-626.
16. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G: Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002;40:728-736.
17. Chan CT, Floras JS, Miller JA, Richardson RMA, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002;61:2235-2239.
18. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998;54:1720-1725.
19. Goodman WG, London G, Amann K, et al: Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004;43:572-579.
20. Davies MR, Hruska KA: Pathophysiological mechanisms of vascular calcification in endstage renal disease. Kidney Int 2001;60:472-479.
21. Koenig W, Sund M, Fröhlich M, et al: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-242.
22. Park CW, Shin YS, Kim CM, et al: Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002;40:1230-1239.
23. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin N, Mitch WE: Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 2004;65:1408-1415.
24. Beddhu S, Pappas LM, Ramkumar N, Samore MH: Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol 2004;15:733-742.
25. Iseki K, Miyasato F, Tokuyama K, et al: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997;51:1212-1217.
26. Zager PG, Nikolic J, Brown RH, et al: 'U' curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;54:561-569.
27. Port FK, Hulbert-Shearon TE, Wolfe RA, et al: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999;33:507-517.
28. Peranzella MA: Approach to patients with intradialytic hypotension: a focus on therapeutic options. Semin Dial 1999;12:175-181.
29. Horl MP, Horl WH: Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 2002;39:227-244.
30. Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N: Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 2005;45:112-118.
31. Takeda A, Toda T, Fujii T, Sasaki S, Matsui N: Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients? Nephron 2006;103:137-143.